<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Breast & Hernia Procedures Stall: Q420/FY20 US Surgical Matrices Market Recap

3/11/21 9:20 AM

Q420 US Surgical Matrices Recap-1The recovery in breast and hernia procedure stalled in Q420, with revenue dropping -9.2% YoY, according to BioMedGPS’ SmartTRAK Financial DashboardAbbVie* maintained its lead despite the effects of the pandemic, off -8.4% YoY, as its breast matrices continued to lag in the overall recovery. Becton Dickinson* (BD) slid –1.2% YoY as hernia procedures bounced back to normal levels a little faster ...

Among the many topics covered in the comprehensive Q420/FY20 US Surgical Matrices Market Recap* are:
  • Complete US Surgical Matrices Market Overview
  • Companies' Revenues and Market Shares
  • US Surgical Matrices Market Rebounds Toward Pre-COVID-19 Levels
  • US Breast Matrices: One Step Forward, Two Steps Back
  • US Hernia Repair Matrices Market: Coming Back From COVID-19
  • Important Q420 events in the US Surgical Matrices Market

In Q420, Integra* announced a definitive agreement to acquire ACell for $300MM plus an additional $100MM based on milestones. In 2019, ACell had revenue of $100.8MM. The deal closed in Q121. BD announced it is increasing its R&D spending in its Interventional business in order to ...

Read the entire Q420/FY20 US Hemostats and Sealants Market Recap including news, data, charts, company revenues, shares and analysis*

*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.

Learn More

SmartTRAK is a comprehensive, easy-to-use, business intelligence solution that networks an entire organization with real-time market data and analysis. Used by the 15 top Advanced Wound Care companies and 8 of the 10 top Orthopedic companies, SmartTRAK transforms the delivery of healthcare business information into a cost-effective solution for life science corporations to increase proficiency, improve productivity and reduce cost.

Topics: Wound Care

Doug Devens
Written by Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles